Heidelberg Pharma AG (ETR:HPHA)
Germany · Delayed Price · Currency is EUR 3.070
+0.010 (0.33%)
At close: Mar 6, 2026
Heidelberg Pharma AG Market Cap
Heidelberg Pharma AG has a market cap or net worth of €143.61 million as of March 6, 2026. Its market cap has increased by 27.86% in one year.
Market Cap
143.61M
Enterprise Value
120.88M
Revenue
3.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.07
Market Cap Chart
Since November 13, 2006, Heidelberg Pharma AG's market cap has decreased from 158.11M to 143.61M, a decrease of -9.17%. That is a compound annual growth rate of -0.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 143.61M | 23.79% |
| Dec 30, 2025 | 116.01M | 2.02% |
| Dec 30, 2024 | 113.72M | -34.75% |
| Dec 29, 2023 | 174.28M | -24.11% |
| Dec 30, 2022 | 229.66M | 41.34% |
| Dec 30, 2021 | 162.49M | -24.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 47.89B |
| Siemens Healthineers AG | 45.09B |
| Bayer Aktiengesellschaft | 35.75B |
| Fresenius SE & Co. KGaA | 26.32B |
| Formycon AG | 348.70M |
| M1 Kliniken AG | 288.35M |
| Stratec SE | 237.04M |
| MEDICLIN Aktiengesellschaft | 179.55M |